George P Hess

Title: George P. Hess: Innovator in Alzheimer's Research

Introduction

George P. Hess is a notable inventor based in Ithaca, NY (US), recognized for his contributions to the field of Alzheimer's research. He holds a total of 4 patents, showcasing his innovative approach to addressing complex medical challenges.

Latest Patents

Among his latest patents is the invention titled "Inhibition of beta-amyloid peptide aggregation." This invention relates to methods of using cocaine-binding-site ligands and cocaine-binding-site RNA aptamers to treat or prevent Alzheimer's Disease. It aims to reduce or prevent the aggregation of beta-amyloid peptides in a subject, which is a significant factor in the progression of the disease. Another notable patent is "Protecting group for carboxylic acids that can be photolyzed by visible light." This invention involves a photolabile compound that includes a coumarin family caging group covalently bound to an organic moiety containing a carboxyl group, an amino group, a sulfhydryl group, and/or a hydroxyl group. Upon absorbing visible light, this compound releases the organic moiety, providing a method for obtaining biologically active compounds in a sample.

Career Highlights

George P. Hess is affiliated with the Cornell Research Foundation Inc., where he continues to advance his research and innovations. His work has significantly impacted the understanding and treatment of Alzheimer's Disease, contributing to the broader field of neurodegenerative research.

Collaborations

Throughout his career, George has collaborated with esteemed colleagues, including Barry K. Carpenter and Doraiswamy Ramesh. These collaborations have fostered a rich environment for innovation and discovery in their respective fields.

Conclusion

George P. Hess exemplifies the spirit of innovation in medical research, particularly in the fight against Alzheimer's Disease. His patents and ongoing work continue to inspire advancements in the field.